SL Science Holding Ltd (SLBT) News & Events

$1.530

-0.020 (-1.29%)At close

SLBT News

SL Science Holding Reports Positive Data for Glioblastoma Treatment

SL Science Holding Files New Drug Master File with FDA

SL Science Files New Drug Master File with FDA

Biotech Stocks Surge with Significant Gains

SL Science Showcases γδ T Cell Therapy for Glioblastoma

SL Science Submits Orphan Drug Designation for Brain Cancer Treatment

SL Science Holding Submits Orphan Drug Designation for GBM Therapy

Biotech Companies See Significant Stock Gains

SL Science Reports 2025 Financial Results and Strategic Shift

Biotech Companies Achieve Significant Milestones

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.